Bridging disciplines to create a new solution for central and arterial line placement – GT Capstone Day at GCMI: S.A.V.A.G.E.

Georgia Tech Biomedical Engineering students Robert Bridenhagen, Gabriel Cruz, and Annika Clawson teamed up with Computer Engineering student Matthew Aspinwall and Electrical Engineering student Matthew Zilvetti to form the interdisciplinary team S.A.V.A.G.E. 

The most expensive study is one you have to repeat. 10 things to know before you start your GLP study.

Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a  legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…

Join GCMI as we take a look into the future of spine therapy innovation at NASS 2019

The North American Spine Society (NASS) Annual Meeting is the gathering with arguably the greatest ability to influence the global market for spinal implants and devices, its innovation and growth. T3 Labs Orthopedic Program Director Dr. Evan Goldberg, a long-time veteran of this industry-leading spine conference, will be onsite at NASS 2019 in Chicago on September 25-28.

Looking to engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2019!

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 25-29, 2019 in San Francisco, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year, and our booth number is A2118.

Need help moving a medtech device through development and regulatory pathways? Connect with T3 Labs at ASAIO 2019.

At GCMI, medtech and medical device innovation are at the core of our efforts including our work within our industry leading preclinical CRO. While our team constantly focuses on the advancement of our sponsors’ journeys from concept to commercialization to cure, we actively seek to attend events that connect us with medtech innovators across the…

GCMI and Rambam Medical Center Accelerator Evaluating 12 Israeli Startups for U.S. Commercialization.

In October 2018, GCMI and Rambam Medical Center announced the formation of a partnership to help Israeli medtech innovators commercialize their products in the U.S. healthcare market. Earlier this year, Georgia Bio and the Atlanta Chamber of Commerce recognized our work with a 2019 Phoenix Award recognizing leaders who have forged academic and industry relationships…